Status:
COMPLETED
ARTiBIOME: Observational Study on the Effect of HIV and ART on Gut Microbiome
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HIV Infections
Eligibility:
MALE
18+ years
Brief Summary
Antiretroviral treatment for HIV has allowed patients to have undetectable viral load indefinitely. Despite that, HIV infection has become a chronic inflammatory disease, with increased mortality. Thi...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Willing to sign consent form
- Men with an age \>18 years
- Engagement in insertive or receptive anal intercourse with another men
- \*Exclusion criteria:
- Previous history of ART exposure
- Use of antibiotics in the past 3 months
- Previous history of inflammatory bowel disease, autoimmune disease or cirrhosis.
Exclusion
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04460924
Start Date
November 1 2020
End Date
March 1 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Ramón y Cajal and Hospital Clínico San Carlos
Madrid, Spain, 28034